ABCC2 (Q92887) variants and mutations
ABCC2 (also known as Q92887) is a human protein-coding gene encoding an ATP-binding cassette sub-family C member 2 protein. It moves bilirubin conjugates, glutathione conjugates, drugs, and other organic anions from hepatocytes into bile. Loss-of-function variants cause Dubin-Johnson syndrome with chronic conjugated hyperbilirubinemia. This analysis covers 2,064 ABCC2 variants and mutations. Of these, 89% have computational variant effect predictions. Disease context includes Dubin-Johnson syndrome, Intrahepatic cholestasis of pregnancy, and cholestasis. Example ABCC2 variants include M1I, L2L, and L2P.
Variant analysis overview
- Gene: ABCC2
- Protein: Q92887
- UniProt accession: Q92887
- Organism: Homo sapiens
- Variants analyzed: 2064
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 1,854 unspecified-consequence records; 87 synonymous variants; 90 missense variants; 17 frameshift variants; 3 splice-region variants; 6 stop-gained variants; 3 in-frame deletions; 1 in-frame insertions; 2 substitution
- Prediction scores: 1,845 variants have prediction scores (89% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Dubin-Johnson syndrome, Intrahepatic cholestasis of pregnancy, cholestasis, hereditary disease, autosomal recessive inherited pseudoxanthoma elasticum, Abnormality of the liver, prostatitis, hypothyroidism, cataract, progressive familial intrahepatic cholestasis, non-small cell lung carcinoma, Crigler-Najjar syndrome type 2.
Protein structure and variant hotspots
- Protein features: 17 transmembrane segments; 4 domains; 2 binding sites; 10 post-translational modification sites.
- Structural context: 1,526 variants have structural context.
- PTM context: 9 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ABCC2 variants
Examples include M1I, L2L, L2P, E3Q, K4R, K4N, F5L, F5S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs1309534430, ClinGen CA378100092, ClinVar RCV003894756, MetaLR 0.52, MetaSVM -0.18, Uncertain significance, ABCC2-related disorder
- L2L (p.Leu2Leu), rs769813554, gnomAD 10-99782848-C-T, CADD 9.69
- L2P (p.Leu2Pro), gnomAD 10-99782849-T-C, CADD 26.90, PolyPhen-2 0.88
- E3Q (p.Glu3Gln), ExAC rs749476023, gnomAD rs749476023, CADD 23.90, PolyPhen-2 0.37
- K4R (p.Lys4Arg), Ensembl rs2037638821, CADD 13.80, PolyPhen-2 0.08
- K4N (p.Lys4Asn), gnomAD 10-99782856-G-C, CADD 3.16, PolyPhen-2 0.08
- F5L (p.Phe5Leu), NCI-TCGA Cosmic COSV6497, cosmic curated COSV64971, Ensembl rs2037638876, CADD 23.00, PolyPhen-2 0.13, Variant assessed as somatic; moderate impact.
- F5S (p.Phe5Ser), TOPMed rs1266994286
- C6R (p.Cys6Arg), TOPMed rs1208413085, gnomAD rs1208413085, CADD 29.20
- C6Y (p.Cys6Tyr), ExAC rs769004636, gnomAD rs769004636, CADD 24.50, PolyPhen-2 0.16
- C6C (p.Cys6Cys), rs1255399298, gnomAD 10-99782862-C-T, CADD 15.20
- N7S (p.Asn7Ser), TOPMed rs2037639136, CADD 18.50, PolyPhen-2 0.05
- S8F (p.Ser8Phe), rs375147383, ClinGen CA5642748, ClinVar RCV000733111, ClinVar RCV001103774, CADD 24.50, PolyPhen-2 0.06, Uncertain significance, not provided; Dubin-Johnson syndrome
- S8P (p.Ser8Pro), gnomAD 10-99782866-T-C, CADD 29.20, PolyPhen-2 0.82
- T9T (p.Thr9Thr), rs1259112303, gnomAD 10-99782871-T-A, CADD 7.67
- F10S (p.Phe10Ser), gnomAD rs1420969492, CADD 25.50, PolyPhen-2 0.27
- F10V (p.Phe10Val), ExAC rs748623159, TOPMed rs748623159, gnomAD rs748623159, CADD 24.80, PolyPhen-2 0.44
- F10F (p.Phe10Phe), rs2132936470, gnomAD 10-99782874-T-C, CADD 13.80
- W11* (p.Trp11Ter), TOPMed rs2037639429
- W11G (p.Trp11Gly), gnomAD 10-99782870-CT-C, CADD 17.50
- N12S (p.Asn12Ser), Ensembl rs2132941523
- N12N (p.Asn12Asn), rs1400448508, gnomAD 10-99784610-T-C, CADD 9.37
- S13F (p.Ser13Phe), gnomAD 10-99784612-C-T, CADD 17.20, PolyPhen-2 0.01
- S14L (p.Ser14Leu), gnomAD 10-99784615-C-T, CADD 26.80, PolyPhen-2 0.91
- F15L (p.Phe15Leu), TOPMed rs1193992791, gnomAD rs1193992791, CADD 7.63, PolyPhen-2 0.00
- D17E (p.Asp17Glu), gnomAD rs1414407577, CADD 6.01, PolyPhen-2 0.01
- D17G (p.Asp17Gly), gnomAD 10-99784624-A-G, CADD 25.20, PolyPhen-2 0.12
- D17D (p.Asp17Asp), gnomAD 10-99784625-C-T, CADD 4.96
- S18T (p.Ser18Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P19L (p.Pro19Leu), rs141278106, ClinGen CA5642767, cosmic curated COSV10943, ClinVar RCV001103776, CADD 21.50, PolyPhen-2 0.22, Uncertain significance, Dubin-Johnson syndrome; not provided
- P19P (p.Pro19Pro), rs772618481, gnomAD 10-99784631-G-C, CADD 0.97
- E20G (p.Glu20Gly), gnomAD rs1433080106, CADD 25.70, PolyPhen-2 0.22
- A21G (p.Ala21Gly), ExAC rs747479981, gnomAD rs747479981, CADD 22.20, PolyPhen-2 0.43
- A21P (p.Ala21Pro), gnomAD 10-99784635-G-C, CADD 15.30, PolyPhen-2 0.00
- D22A (p.Asp22Ala), cosmic curated COSV64971, ExAC rs769292618, TOPMed rs769292618, gnomAD rs769292618, CADD 29.60, PolyPhen-2 1.00
- D22G (p.Asp22Gly), ExAC rs769292618, TOPMed rs769292618, gnomAD rs769292618, CADD 32.00, PolyPhen-2 1.00
- D22H (p.Asp22His), gnomAD 10-99784638-G-C, CADD 31.00, PolyPhen-2 1.00
- D22E (p.Asp22Glu), gnomAD 10-99784640-C-A, CADD 24.40, PolyPhen-2 1.00
- D22D (p.Asp22Asp), rs774887685, gnomAD 10-99784640-C-T, CADD 12.60
- L23L (p.Leu23Leu), gnomAD 10-99784641-C-T, CADD 11.50
- L23R (p.Leu23Arg), gnomAD 10-99784642-T-G, CADD 28.70, PolyPhen-2 0.98
- P24Q (p.Pro24Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P24S (p.Pro24Ser), ExAC rs762628115, gnomAD rs762628115, CADD 22.90, PolyPhen-2 0.66
- P24P (p.Pro24Pro), rs763624698, gnomAD 10-99784646-A-G, CADD 8.00
- L25F (p.Leu25Phe), gnomAD 10-99784646-AC-A, CADD 26.00
- C26Y (p.Cys26Tyr), ESP rs150765440, ExAC rs150765440, gnomAD rs150765440, CADD 28.90, PolyPhen-2 1.00
- C26S (p.Cys26Ser), gnomAD 10-99784651-G-C, CADD 28.10, PolyPhen-2 1.00
- F27S (p.Phe27Ser), gnomAD 10-99784654-T-C, CADD 31.00, PolyPhen-2 0.85
- E28E (p.Glu28Glu), rs2037674292, gnomAD 10-99784658-G-A, CADD 6.37
- Q29R (p.Gln29Arg), ExAC rs761583735, gnomAD rs761583735, CADD 22.80, PolyPhen-2 0.22
- Q29* (p.Gln29Ter), gnomAD 10-99784659-C-T, CADD 37.00
- Q29Q (p.Gln29Gln), gnomAD 10-99784661-A-G, CADD 11.20
- T30S (p.Thr30Ser), rs562413451, ClinGen CA5642777, ClinVar RCV004419980, 1000Genomes rs562413451, CADD 24.10, PolyPhen-2 1.00, Uncertain significance, Inborn genetic diseases
- T30T (p.Thr30Thr), rs1035137482, gnomAD 10-99784664-T-C, CADD 13.90
- V31A (p.Val31Ala), Ensembl rs1564665958, CADD 27.00, PolyPhen-2 0.67
- V31I (p.Val31Ile), Ensembl rs2037674506
- L32P (p.Leu32Pro), TOPMed rs1172766973
- L32V (p.Leu32Val), Ensembl rs1182566622
- L32L (p.Leu32Leu), rs1253052762, gnomAD 10-99784670-G-A, CADD 9.16
- V33L (p.Val33Leu), ESP rs139131305, ExAC rs139131305, TOPMed rs139131305, gnomAD rs139131305, CADD 25.80, PolyPhen-2 1.00
- V33M (p.Val33Met), ESP rs139131305, ExAC rs139131305, TOPMed rs139131305, gnomAD rs139131305, CADD 26.30, PolyPhen-2 1.00
- V33G (p.Val33Gly), gnomAD 10-99784672-T-G, CADD 27.20, PolyPhen-2 1.00
- V33V (p.Val33Val), rs376241522, gnomAD 10-99784673-G-A, CADD 8.93
- W34S (p.Trp34Ser), ExAC rs766440827, gnomAD rs766440827, CADD 32.00, PolyPhen-2 1.00
- W34* (p.Trp34Ter), gnomAD 10-99784676-G-A, CADD 39.00
- I35T (p.Ile35Thr), Ensembl rs757900831
- P36L (p.Pro36Leu), ESP rs368821808, ExAC rs368821808, TOPMed rs368821808, gnomAD rs368821808, CADD 27.30, PolyPhen-2 1.00
- L37F (p.Leu37Phe), NCI-TCGA TCGA novel, CADD 25.80, PolyPhen-2 0.91, Variant assessed as somatic; moderate impact.
- L37V (p.Leu37Val), rs755131559, ClinGen CA5642782, ClinVar RCV004417723, ExAC rs755131559, CADD 22.20, PolyPhen-2 0.54, Uncertain significance, Inborn genetic diseases
- L37L (p.Leu37Leu), gnomAD 10-99784683-T-C, CADD 9.19
- L37W (p.Leu37Trp), gnomAD 10-99784684-T-G, CADD 28.70, PolyPhen-2 0.99
- G38C (p.Gly38Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G38D (p.Gly38Asp), Ensembl rs2037675235
- Y39* (p.Tyr39Ter), Ensembl rs1590134009, CADD 37.00
- Y39C (p.Tyr39Cys), 1000Genomes rs927344, ESP rs927344, ExAC rs927344, TOPMed rs927344, Benign
- Y39F (p.Tyr39Phe), rs927344, ClinGen CA5642784, cosmic curated COSV10746, ClinVar RCV000988441, CADD 19.60, PolyPhen-2 0.00, Benign, not provided; Dubin-Johnson syndrome; not specified
- Y39S (p.Tyr39Ser), 1000Genomes rs927344, ESP rs927344, ExAC rs927344, TOPMed rs927344, Benign
- Y39G (p.Tyr39Gly), gnomAD 10-99784688-C-CGG, CADD 29.80
- Y39H (p.Tyr39His), gnomAD 10-99784689-T-C, CADD 24.50, PolyPhen-2 0.17
- L40P (p.Leu40Pro), rs1257093850, Ensembl rs1257093850, AlphaMissense 0.95, MetaLR 0.45, Variant assessed as somatic; moderate impact.
- L40G (p.Leu40Gly), gnomAD 10-99784690-A-ATG, CADD 28.10
- L40L (p.Leu40Leu), rs758773571, gnomAD 10-99784694-A-G, CADD 9.68
- W41* (p.Trp41Ter), gnomAD 10-99784697-G-A, CADD 40.00
- A44V (p.Ala44Val), gnomAD rs1395260791, CADD 21.90, PolyPhen-2 0.17
- P45S (p.Pro45Ser), gnomAD rs1443387807, CADD 25.20, PolyPhen-2 0.72, Uncertain significance, not provided
- P45A (p.Pro45Ala), gnomAD 10-99784707-C-G, CADD 24.80, PolyPhen-2 0.91
- W46R (p.Trp46Arg), rs778300481, ClinGen CA5642786, ClinVar RCV000596062, ExAC rs778300481, CADD 24.90, PolyPhen-2 0.63, Uncertain significance, not provided
- W46L (p.Trp46Leu), gnomAD 10-99784704-G-GC, CADD 32.00
- Q47* (p.Gln47Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q47K (p.Gln47Lys), cosmic curated COSV10821, TOPMed rs1444324174, gnomAD rs1444324174, CADD 20.80
- Q47H (p.Gln47His), gnomAD 10-99784715-G-C, CADD 15.60, PolyPhen-2 0.00
- L48F (p.Leu48Phe), gnomAD 10-99784716-C-T, CADD 19.30, PolyPhen-2 0.03
- L49F (p.Leu49Phe), NCI-TCGA Cosmic COSV6497, cosmic curated COSV64970, Variant assessed as somatic; moderate impact.
- H50P (p.His50Pro), TOPMed rs1281231157, gnomAD rs1281231157, CADD 14.30
- H50Y (p.His50Tyr), gnomAD 10-99784722-C-T, CADD 7.32, PolyPhen-2 0.13
- H50R (p.His50Arg), gnomAD 10-99784723-A-G, CADD 12.90, PolyPhen-2 0.00
- H50H (p.His50His), rs200595851, gnomAD 10-99784724-C-T, CADD 1.52
- V51L (p.Val51Leu), 1000Genomes rs147471996, ESP rs147471996, ExAC rs147471996, TOPMed rs147471996, CADD 7.16, PolyPhen-2 0.00, Uncertain significance
- V51M (p.Val51Met), 1000Genomes rs147471996, ESP rs147471996, ExAC rs147471996, TOPMed rs147471996, CADD 14.00, PolyPhen-2 0.03, Uncertain significance, Inborn genetic diseases
- V51V (p.Val51Val), gnomAD 10-99784727-G-A, CADD 1.13
- Y52* (p.Tyr52Ter), rs1554845888, ClinGen CA378100916, ClinVar RCV000594763, ClinVar RCV003953002, Pathogenic
- Y52C (p.Tyr52Cys), gnomAD 10-99784729-A-G, CADD 15.50, PolyPhen-2 0.00
- K53K (p.Lys53Lys), rs17222596, gnomAD 10-99784733-A-G, CADD 7.52
- S54F (p.Ser54Phe), gnomAD 10-99784735-C-T, CADD 19.20, PolyPhen-2 0.37
- S54S (p.Ser54Ser), rs748727152, gnomAD 10-99784736-C-G, CADD 7.75
- R55G (p.Arg55Gly), ExAC rs768214282, gnomAD rs768214282, CADD 16.40, PolyPhen-2 0.00
- p.Arg55 Thr56del, rs752853724, gnomAD 10-99784734-TCCAG, CADD 15.00
- R55K (p.Arg55Lys), gnomAD 10-99784738-G-A, CADD 12.40, PolyPhen-2 0.00
- R55R (p.Arg55Arg), rs1295970990, gnomAD 10-99784739-G-A, CADD 6.67
- T56T (p.Thr56Thr), gnomAD 10-99784742-C-T, CADD 6.69
- K57M (p.Lys57Met), ExAC rs761468521, gnomAD rs761468521, AlphaMissense 0.19, MetaLR 0.10, Uncertain significance
- K57Q (p.Lys57Gln), rs145346144, ClinGen CA5642793, ClinVar RCV001105714, ClinVar RCV004649456, CADD 17.00, PolyPhen-2 0.01, Uncertain significance, Dubin-Johnson syndrome; Inborn genetic diseases
- K57R (p.Lys57Arg), rs761468521, ClinGen CA378100947, ClinVar RCV001329234, ExAC rs761468521, AlphaMissense 0.19, MetaLR 0.10, Uncertain significance, Dubin-Johnson syndrome
- K57E (p.Lys57Glu), gnomAD 10-99784743-A-G, CADD 17.50, PolyPhen-2 0.06
- R58R (p.Arg58Arg), gnomAD 10-99784746-A-C, CADD 10.90
- S59P (p.Ser59Pro), Ensembl rs1474310307
- S59T (p.Ser59Thr), gnomAD 10-99784749-T-A, CADD 15.30, PolyPhen-2 0.07
- S59Y (p.Ser59Tyr), gnomAD 10-99784750-C-A, CADD 9.15, PolyPhen-2 0.00
- S59S (p.Ser59Ser), rs771802870, gnomAD 10-99784751-C-T, CADD 0.97
- S60F (p.Ser60Phe), Ensembl rs2037676825
- S60P (p.Ser60Pro), Ensembl rs2037676760
- S60S (p.Ser60Ser), gnomAD 10-99784754-T-C, CADD 7.72
- T61A (p.Thr61Ala), gnomAD rs1438020162, CADD 3.68, PolyPhen-2 0.00
- T61I (p.Thr61Ile), gnomAD 10-99784756-C-T, CADD 0.32, PolyPhen-2 0.00
- T61T (p.Thr61Thr), gnomAD 10-99784757-C-A, CADD 0.70
- T62S (p.Thr62Ser), gnomAD rs1183047323, CADD 14.60, PolyPhen-2 0.08
- T62T (p.Thr62Thr), gnomAD 10-99784760-C-T, CADD 9.55
- K63N (p.Lys63Asn), 1000Genomes rs41286890, ExAC rs41286890, TOPMed rs41286890, gnomAD rs41286890, CADD 18.80, Likely benign
- K63T (p.Lys63Thr), gnomAD 10-99784762-A-C, CADD 18.10, PolyPhen-2 0.01
- K63K (p.Lys63Lys), rs41286890, gnomAD 10-99784763-A-G, CADD 9.25
- L64F (p.Leu64Phe), gnomAD rs1471915301, CADD 17.80, PolyPhen-2 0.01
- L64H (p.Leu64His), NCI-TCGA Cosmic COSV6497, cosmic curated COSV64971, Variant assessed as somatic; moderate impact.
- L64R (p.Leu64Arg), gnomAD rs1321894236, CADD 25.40, PolyPhen-2 0.63
- L64L (p.Leu64Leu), rs1246731783, gnomAD 10-99784766-C-T, CADD 8.18
- Y65C (p.Tyr65Cys), ExAC rs766200636, TOPMed rs766200636, gnomAD rs766200636, CADD 24.60, PolyPhen-2 0.94
- Y65S (p.Tyr65Ser), ExAC rs766200636, TOPMed rs766200636, gnomAD rs766200636, CADD 23.90, PolyPhen-2 0.88, Uncertain significance, Inborn genetic diseases
- L66I (p.Leu66Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L66V (p.Leu66Val), TOPMed rs2037677277, gnomAD rs2037677277, CADD 12.70
- A67T (p.Ala67Thr), gnomAD 10-99784773-G-A, CADD 17.10, PolyPhen-2 0.01
- K68T (p.Lys68Thr), rs375805189, ClinGen CA5642799, ClinVar RCV001403390, ClinVar RCV003365381, CADD 26.20, PolyPhen-2 0.66, Conflicting interpretations, not provided; Inborn genetic diseases
- Q69P (p.Gln69Pro), rs145427140, ClinGen CA5642800, ClinVar RCV000728428, 1000Genomes rs145427140, CADD 31.00, PolyPhen-2 0.69, Uncertain significance, not provided
- Q69E (p.Gln69Glu), gnomAD 10-99784779-C-G, CADD 20.90, PolyPhen-2 0.01
- Q69R (p.Gln69Arg), gnomAD 10-99784780-A-G, CADD 26.00, PolyPhen-2 0.26
- V70A (p.Val70Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V70G (p.Val70Gly), rs2492836176, ClinGen CA378101713, ClinVar RCV003372154, Uncertain significance, Inborn genetic diseases
- V70I (p.Val70Ile), rs199700510, ClinGen CA5642814, ClinVar RCV000596839, ClinVar RCV004024738, CADD 23.90, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases; not provided
- V70L (p.Val70Leu), ExAC rs199700510, TOPMed rs199700510, gnomAD rs199700510, CADD 27.80, PolyPhen-2 0.01, Uncertain significance
- F71L (p.Phe71Leu), ExAC rs770824435, TOPMed rs770824435, gnomAD rs770824435, CADD 0.03, PolyPhen-2 0.00, Likely benign
- F71F (p.Phe71Phe), rs770824435, gnomAD 10-99792239-C-T, CADD 1.39
- V72A (p.Val72Ala), rs765361901, ClinGen CA5642818, ClinVar RCV002821835, ExAC rs765361901, CADD 18.60, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases
- V72I (p.Val72Ile), rs148791847, ClinGen CA5642817, cosmic curated COSV64971, ClinVar RCV001105715, CADD 23.00, PolyPhen-2 0.05, Uncertain significance, Dubin-Johnson syndrome
- G73D (p.Gly73Asp), Ensembl rs2037822163
- G73G (p.Gly73Gly), rs752859125, gnomAD 10-99792245-T-C, CADD 7.64
- L75F (p.Leu75Phe), Ensembl rs2037822338
- L75L (p.Leu75Leu), rs2132966039, gnomAD 10-99792251-T-C, CADD 11.40
- L76P (p.Leu76Pro), gnomAD rs1229176388, CADD 28.50, PolyPhen-2 0.72
- L76del (p.Leu76del), rs758343622, gnomAD 10-99792246-TTTC-, CADD 19.80
- I77V (p.Ile77Val), ExAC rs763168977, gnomAD rs763168977, CADD 16.40, PolyPhen-2 0.00
- L78L (p.Leu78Leu), rs764390911, gnomAD 10-99792258-C-T, CADD 10.00
- A80P (p.Ala80Pro), gnomAD 10-99792263-AG-A, CADD 29.10
- A80A (p.Ala80Ala), gnomAD 10-99792266-C-T, CADD 11.90, SIFT 0.09
- I81T (p.Ile81Thr), gnomAD 10-99792268-T-C, CADD 20.80, PolyPhen-2 0.40
- L83R (p.Leu83Arg), TOPMed rs1199759177, gnomAD rs1199759177, CADD 26.50
- L83V (p.Leu83Val), ExAC rs757560484, gnomAD rs757560484, CADD 11.00, PolyPhen-2 0.16
- A84G (p.Ala84Gly), gnomAD rs1484538477, CADD 5.30, PolyPhen-2 0.00
- A84T (p.Ala84Thr), NCI-TCGA Cosmic COSV1009, cosmic curated COSV10096, Variant assessed as somatic; moderate impact.
- A84A (p.Ala84Ala), rs781624569, gnomAD 10-99792278-C-T, CADD 7.21
- L85V (p.Leu85Val), rs750844583, ClinGen CA5642826, ClinVar RCV003208381, ExAC rs750844583, CADD 8.56, PolyPhen-2 0.03, Uncertain significance, Inborn genetic diseases
- L85P (p.Leu85Pro), gnomAD 10-99792280-T-C, CADD 24.60, PolyPhen-2 0.91
- L85L (p.Leu85Leu), rs1429136604, gnomAD 10-99792281-T-A, CADD 9.46
- V86A (p.Val86Ala), gnomAD rs1190592190, CADD 10.90, PolyPhen-2 0.00
- V86E (p.Val86Glu), gnomAD rs1190592190
- V86L (p.Val86Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V86V (p.Val86Val), rs142443276, gnomAD 10-99792284-A-G, CADD 7.39
- L87F (p.Leu87Phe), Ensembl rs959197182
- T88A (p.Thr88Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T88K (p.Thr88Lys), rs1564669915, ClinGen CA378101818, ClinVar RCV000729561, Ensembl rs1564669915, AlphaMissense 0.16, MetaLR 0.07, Uncertain significance, not provided
- T88R (p.Thr88Arg), Ensembl rs1564669915, AlphaMissense 0.16, MetaLR 0.07, Uncertain significance
- E89D (p.Glu89Asp), Ensembl rs2037823120
- E89K (p.Glu89Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public ABCC2 analysis runs
- ABCC2 analysis run — ABCC2 (2,064 variants) — completed 2026-08-18